XML 74 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Operating Activities      
Net income $ 17,658 $ 30,977 $ 34,938
Adjustments to reconcile net income to net cash provided by/(used in) operating activities:      
Depreciation 57,182 56,769 57,502
Amortization 6,607 6,466 8,883
Noncash interest expense    1,027 753
Change in long-term liabilities, deferred taxes and other credits (12,261) (123,887) 237
Provision for write-off of property, plant and equipment 619 427 2,345
Write-off of pension liability adjustment due to settlement    118,350   
Loss/(gain) on disposition of assets (3,763) (92,457) (1,022)
Excess tax benefit of options exercised (1,134) (40) (93)
Compensation and benefits paid or payable in Class A Common Stock (766) 2,790 2,812
Changes in operating assets and liabilities, net of business divestitures:      
Accounts receivable (8,878) (4,990) (12,082)
Inventories 5,739 11,565 7,105
Prepaid expenses and other current assets 545 592 314
Income taxes prepaid and receivable 5,731 9,472 (3,747)
Accounts payable 955 3,298 (1,677)
Accrued liabilities 4,628 7,616 6,124
Income taxes payable (7,348) 7,308 2,422
Other, net (2,883) (776) 455
Net cash provided by operating activities 62,631 34,507 105,269
Investing Activities      
Purchases of property, plant and equipment (61,844) (37,046) (24,988)
Purchased software (2,613) (161) (3,692)
Proceeds from sale of assets 6,268    2,860
Proceeds from sale of discontinued operations, net of expenses 16,797 150,654   
Net cash (used in)/provided by investing activities (41,392) 113,447 (25,820)
Financing Activities      
Proceeds from borrowings 117,452 46,028 14,386
Principal payments on debt (132,691) (102,128) (65,575)
Cash received for noncontrolling interest in Albany Safran Composites 28,000      
Proceeds from options exercised 5,538 1,311 789
Excess tax benefit of options exercised 1,134 40 93
Debt acquisition costs (1,639)      
Dividends paid (13,929) (21,315) (15,616)
Net cash provided by/(used in) financing activities 3,865 (76,064) (65,923)
Effect of exchange rate changes on cash and cash equivalents 6,844 (81) (3,373)
Increase in cash and cash equivalents 31,948 71,809 10,153
Change in cash balances of discontinued operations       (9,169)
Cash and cash equivalents at beginning of year 190,718 118,909 117,925
Cash and cash equivalents at end of year $ 222,666 $ 190,718 $ 118,909